These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17960812)

  • 1. Molding the sensory cortex: spatial acuity improves after botulinum toxin treatment for cervical dystonia.
    Walsh R; Hutchinson M
    Mov Disord; 2007 Dec; 22(16):2443-6. PubMed ID: 17960812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
    Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
    Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
    Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
    Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
    Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
    Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
    Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
    Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal discrimination threshold: VBM evidence for an endophenotype in adult onset primary torsion dystonia.
    Bradley D; Whelan R; Walsh R; Reilly RB; Hutchinson S; Molloy F; Hutchinson M
    Brain; 2009 Sep; 132(Pt 9):2327-35. PubMed ID: 19525326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatosensory temporal discrimination tested in patients receiving botulinum toxin injection for cervical dystonia.
    Scontrini A; Conte A; Fabbrini G; Colosimo C; Di Stasio F; Ferrazzano G; Berardelli A
    Mov Disord; 2011 Mar; 26(4):742-6. PubMed ID: 21506155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.
    Haussermann P; Marczoch S; Klinger C; Landgrebe M; Conrad B; Ceballos-Baumann A
    Mov Disord; 2004 Mar; 19(3):303-8. PubMed ID: 15022184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of posttraumatic cervical dystonia.
    Frei KP; Pathak M; Jenkins S; Truong DD
    Mov Disord; 2004 Dec; 19(12):1492-8. PubMed ID: 15390063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disturbed egocentric space representation in cervical dystonia.
    Müller SV; Gläser P; Tröger M; Dengler R; Johannes S; Münte TF
    Mov Disord; 2005 Jan; 20(1):58-63. PubMed ID: 15390129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study of botulinum toxin A for headache in cervical dystonia.
    Ondo WG; Gollomp S; Galvez-Jimenez N
    Headache; 2005 Sep; 45(8):1073-7. PubMed ID: 16109123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse sensory geste in cervical dystonia.
    Asmus F; von Coelln R; Boertlein A; Gasser T; Mueller J
    Mov Disord; 2009 Jan; 24(2):297-300. PubMed ID: 19086084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
    Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
    Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensorimotor network in cervical dystonia and the effect of botulinum toxin treatment: a functional MRI study.
    Opavský R; Hluštík P; Otruba P; Kaňovský P
    J Neurol Sci; 2011 Jul; 306(1-2):71-5. PubMed ID: 21492880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of tactile and visuo-tactile events is impaired in patients with cervical dystonia.
    Tinazzi M; Fiorio M; Bertolasi L; Aglioti SM
    J Neurol; 2004 Jan; 251(1):85-90. PubMed ID: 14999494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia.
    Tassorelli C; Mancini F; Balloni L; Pacchetti C; Sandrini G; Nappi G; Martignoni E
    Mov Disord; 2006 Dec; 21(12):2240-3. PubMed ID: 17029278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The entity of young onset primary cervical dystonia.
    Koukouni V; Martino D; Arabia G; Quinn NP; Bhatia KP
    Mov Disord; 2007 Apr; 22(6):843-7. PubMed ID: 17357144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of botulinum toxin treatment on previous primary headaches in patients with cranio-cervical dystonia].
    Pascual J
    Neurologia; 2004 Jun; 19(5):260-3. PubMed ID: 15150709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic adult onset dystonia: sensory abnormalities as an endophenotype in unaffected relatives.
    Walsh R; O'Dwyer JP; Sheikh IH; O'Riordan S; Lynch T; Hutchinson M
    J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):980-3. PubMed ID: 17702779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.